by Dana Boebinger figures by Tito Adhikary I’ve had many conversations over the past several weeks – with scientists and non-scientists alike – about the possible outcomes of this weekend’s March for Science. Some people are excited about this opportunity to make a strong show of support for scientific research and evidence-based policymaking. Others don’t think a march is necessary. But in the days leading … Continue reading Mixed Emotions on the March for Science and the Consequences of Getting it Wrong
by Garrett Dunlap figures by Daniel Utter Two. Two is the number of current members of Congress that hold PhDs in a STEM field. Representative Bill Foster of Illinois holds a PhD in physics and Representative Jerry McNerney of California holds a PhD in math. In comparison, this is dwarfed by the number of congressmembers with law degrees (222) and those holding just high school … Continue reading Scientists: Why they should run for office and why we should vote for them
Update: Since the writing of this article, Donald Trump has picked Scott Gottleib as FDA commissioner. -SITN editorial staff by Linda Honaker figures by Rebecca Clements Donald Trump will soon pick a new commissioner for the Federal Drug Administration (FDA). The choice will likely be someone who will try to make the administration’s drug approval requirements less rigorous in order to get drugs on the … Continue reading Make the FDA Great Again? Trump and the future of the drug approval process
by Chris Rota figures by Dan Utter In the twilight of the Obama administration, a rare event of compromise between Democrats and Republicans resulted in the successful passage of the 21st Century Cures Act. While the law has a number of implications for healthcare, especially in the area of mental health, its greatest effects are likely to be seen in the area of biomedical research. … Continue reading 21st Century Cures and You: A Guide to Understanding the 21st Century Cures Act
by Christopher Gerry figures by Michael Gerhardt One of the sad ironies of modern medicine is that painkillers, licit and illicit alike, have brought addiction, suffering, and death to communities across the United States. The prevalence of opioid abuse in particular has skyrocketed over the past few years and shows few signs of abating. In 2014, the most recent year for which the Centers for … Continue reading Drugs, data, and public policy: What can science teach lawmakers about the opioid crisis?
by Caitlin Nichols cover image by Rebecca Clements Modern advances in stem cell technology and genetic engineering are bringing the stuff of science fiction into reality, presenting remarkable promise for expanding knowledge and treating disease. However, these developments also arouse ethical concerns that must be considered when deciding if and how to implement them. One striking example of this relationship between biological advancement and bioethics … Continue reading How we talk about science matters: A bioethicist’s view on controversial research and science policy